Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company bioMerieux S.A.
DescriptionMicroarray test based on the TUO (tumor of unknown origin) gene expression profile
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today